Literature DB >> 23931025

What is the most practical, optimal, and cost effective method for performing follow-up after lung cancer surgery, and by whom should it be done?

Lise Tremblay1, Jean Deslauriers.   

Abstract

Surgery is the treatment of choice for early stage non-small cell lung cancer. In this context, postoperative follow-up is important to diagnose late postoperative complications, as well as to detect recurring cancer or new primaries as early as possible. There is, however, no high-quality evidence regarding the benefits of monitoring programs on survival and quality of life. Most studies recommend clinical and radiological follow-up (radiograph or chest computed tomography) performed more intensively during the first two years and annually thereafter. The physician doing the follow-up can be the thoracic surgeon, the diagnosing physician, or the family physician.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Keywords:  Follow-up; Guidelines; Imaging modality; Lung cancer; Surgery

Mesh:

Year:  2013        PMID: 23931025     DOI: 10.1016/j.thorsurg.2013.05.010

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  14 in total

1.  Prognostic Factors of Pathological N1 Non-small Cell Lung Cancer After Curative Resection Without Adjuvant Chemotherapy.

Authors:  Youngkyu Moon; Sook Whan Sung; Jae Kil Park; Kyo Young Lee; Seha Ahn
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

2.  Differing histopathology and prognosis in pulmonary adenocarcinoma at central and peripheral locations.

Authors:  Youngkyu Moon; Kyo Young Lee; Sook Whan Sung; Jae Kil Park
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

3.  Clinicopathological characteristics and prognosis of non-lepidic invasive adenocarcinoma presenting as ground glass opacity nodule.

Authors:  Youngkyu Moon; Sook Whan Sung; Kyo Young Lee; Jae Kil Park
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

4.  Margin Width of Resected Lepidic Lung Cancer Does Not Affect Recurrence After Sublobar Resection.

Authors:  Youngkyu Moon; Kyo Young Lee; Jae Kil Park
Journal:  World J Surg       Date:  2018-05       Impact factor: 3.352

5.  Prognostic factors in stage IB non-small cell lung cancer according to the 8th edition of the TNM staging system after curative resection.

Authors:  Youngkyu Moon; Si Young Choi; Jae Kil Park; Kyo Young Lee
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

6.  The prognosis of invasive adenocarcinoma presenting as ground-glass opacity on chest computed tomography after sublobar resection.

Authors:  Youngkyu Moon; Kyo Young Lee; Jae Kil Park
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

7.  The importance of the lepidic component as a prognostic factor in stage I pulmonary adenocarcinoma.

Authors:  Youngkyu Moon; Sook Whan Sung; Kyo Young Lee; Young Kyoon Kim; Jae Kil Park
Journal:  World J Surg Oncol       Date:  2016-02-16       Impact factor: 2.754

8.  Economic burden of lung cancer: A retrospective cohort study in South Korea, 2002-2015.

Authors:  Soo Min Jeon; Jin-Won Kwon; Sun Ha Choi; Hae-Young Park
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

9.  Prognosis after wedge resection in patients with 8th edition TNM stage IA1 and IA2 non-small cell lung cancer.

Authors:  Youngkyu Moon; Jae Kil Park; Kyo Young Lee; Eun Sung Kim
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

10.  Prognostic prediction of clinical stage IA lung cancer presenting as a pure solid nodule.

Authors:  Jong Hui Suh; Jae Kil Park; Youngkyu Moon
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.